EVerZom raises €1.1m funding to develop its exosome bioproduction platform
– FRANCE, Paris – EVerZom, a biopharmaceutical company specialized in the bioproduction of exosomes, today announced that it has raised €1.1 million funding from institutional and private investors to develop its exosome bioproduction platform.…